Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl Fumarate in Preserving Pancreatic β-Cell Function in Adults With Type 1 Diabetes
NCT07548996Phase 3Recruiting
- Sponsor
- Nanjing Medical University
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimethyl fumarate in type 1 diabetes mellitus (T1D), sponsored by Nanjing Medical University. Started Apr 2026; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07548996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548996.